Comparison Chart Amplia Therapeutics Limited

Stocks

ATX

AU0000023822

Biotechnology & Medical Research

Delayed Australian S.E. 20:00:58 2026-08-24 EDT			5-day change	1st Jan Change
0.1500 ^AUD	0.00%		-3.23%	-

08-03	Amplia Therapeutics to Evaluate Combination Therapy for Non-Small Cell Lung Cancer in Collaboration With Eli Lilly; Shares Rise 7%	MT
08-03	Amplia Therapeutics to Evaluate Combination Therapy for Non-Small Cell Lung Cancer in Collaboration With Eli Lilly	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	AMPLIA THERAPEUTICS LIMITED	Bio Therapeutic Drugs	0.00%	-3.23%	0.00%	-21.05%	-16.67%	55.19M